Literature DB >> 16102988

Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patients.

Ernesto A C Beenakker1, Natalia M Maurits, Johanna M Fock, Oebele F Brouwer, Johannes H van der Hoeven.   

Abstract

Neuromuscular disorders are characterised by progressive muscle weakness, which in time causes functional impairment. To quantify the extent of disease progression, muscle force and functional ability can be measured. Which of these parameters changes most depends on the disease stage. In a previous study, we reported normal values for muscle force obtained by hand-held dynamometry in healthy children aged 4-16 years. In the present study, we report normal values for timed functional tests in healthy children aged 4-11 years. These normal values were compared with values obtained in 16 ambulant patients with Duchenne muscular dystrophy (DMD) aged 5-8 years to study the extent of functional impairment. In ambulant patients with DMD, we found that muscle function assessed by timed functional tests (running 9 m and rising up from the floor) and muscle force assessed by hand-held dynamometry were severely impaired. However, a small reduction of muscle force was accompanied by a large reduction in functional ability. Therefore, in our group of ambulant patients with DMD, timed functional testing was the most sensitive parameter to determine the extent of disease progression. Timed functional testing may therefore be considered as an additional outcome measure in drug trials to evaluate the effects of therapy in ambulant patients with DMD and possibly in other neuromuscular disorders.

Entities:  

Mesh:

Year:  2005        PMID: 16102988     DOI: 10.1016/j.ejpn.2005.06.004

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  24 in total

1.  Two-Year Longitudinal Changes in Lower Limb Strength and Its Relation to Loss in Function in a Large Cohort of Patients With Duchenne Muscular Dystrophy.

Authors:  Abhinandan Batra; Ann Harrington; Donovan J Lott; Rebecca Willcocks; Claudia R Senesac; William McGehee; Dandan Xu; Sunita Mathur; Michael J Daniels; William D Rooney; Sean C Forbes; William Triplett; Jasjit K Deol; Ishu Arpan; Roxanne Bendixen; Richard Finkel; Erika Finanger; Gihan Tennekoon; Barry Byrne; Barry Russman; H Lee Sweeney; Glenn Walter; Krista Vandenborne
Journal:  Am J Phys Med Rehabil       Date:  2018-10       Impact factor: 2.159

2.  Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy.

Authors:  Sunita Mathur; Donovan J Lott; Claudia Senesac; Sean A Germain; Ravneet S Vohra; H Lee Sweeney; Glenn A Walter; Krista Vandenborne
Journal:  Arch Phys Med Rehabil       Date:  2010-07       Impact factor: 3.966

3.  Domains of Daily Physical Activity in Children with Mitochondrial Disease: A 3D Accelerometry Approach.

Authors:  Saskia Koene; Ilse Dirks; Esmee van Mierlo; Pascal R de Vries; Anjo J W M Janssen; Jan A M Smeitink; Arjen Bergsma; Hans Essers; Kenneth Meijer; Imelda J M de Groot
Journal:  JIMD Rep       Date:  2017-01-17

4.  Reliability, validity and description of timed performance of the Jebsen-Taylor Test in patients with muscular dystrophies.

Authors:  Mariana Cunha Artilheiro; Francis Meire Fávero; Fátima Aparecida Caromano; Acary de Souza Bulle Oliveira; Nelson Carvas; Mariana Callil Voos; Cristina Dos Santos Cardoso de Sá
Journal:  Braz J Phys Ther       Date:  2017-12-08       Impact factor: 3.377

5.  Eliminating Nox2 reactive oxygen species production protects dystrophic skeletal muscle from pathological calcium influx assessed in vivo by manganese-enhanced magnetic resonance imaging.

Authors:  James A Loehr; Gary R Stinnett; Mayra Hernández-Rivera; Wesley T Roten; Lon J Wilson; Robia G Pautler; George G Rodney
Journal:  J Physiol       Date:  2016-10-17       Impact factor: 5.182

6.  Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study.

Authors:  Merel Jansen; Imelda Jm de Groot; Nens van Alfen; Alexander Ch Geurts
Journal:  BMC Pediatr       Date:  2010-08-06       Impact factor: 2.125

7.  Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial.

Authors:  Elise Mok; Guy Letellier; Jean-Marie Cuisset; André Denjean; Frédéric Gottrand; Corinne Alberti; Régis Hankard
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

8.  Longitudinal assessment of grip strength using bulb dynamometer in Duchenne Muscular Dystrophy.

Authors:  Tatiana M Pizzato; Cyntia R J A Baptista; Mariana A Souza; Michelle M B Benedicto; Edson Z Martinez; Ana C Mattiello-Sverzut
Journal:  Braz J Phys Ther       Date:  2014-06-24       Impact factor: 3.377

9.  Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy.

Authors:  Roxanna M Bendixen; Donovan J Lott; Claudia Senesac; Sunita Mathur; Krista Vandenborne
Journal:  Disabil Rehabil       Date:  2014-02-06       Impact factor: 3.033

Review 10.  Therapeutics in duchenne muscular dystrophy.

Authors:  Jonathan B Strober
Journal:  NeuroRx       Date:  2006-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.